Homoharringtonine combined with cladribine and aclarubicin (HCA) in acute myeloid leukemia: A new regimen of conventional drugs and its mechanism

OBJECTIVE: The prognosis of children with refractory acute myeloid leukemia (AML) is poor. Complete remission (CR) is not always achieved with current salvage chemotherapy regimens before transplantation, and some patients have no chance of transplantation. Here, we aimed to describe a new regimen o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fenglin, Xie, Min, Chen, Pan, Wang, Dan, Yang, Minghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300287/
https://www.ncbi.nlm.nih.gov/pubmed/35873796
http://dx.doi.org/10.1155/2022/8212286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300287/
https://www.ncbi.nlm.nih.gov/pubmed/35873796
http://dx.doi.org/10.1155/2022/8212286

Ejemplares similares